About The Doctor

Suzanne Schiffman

Complex Abdominal Malignancies , Surgical Oncologist

Dr. Suzanne Schiffman has been specially trained in the field of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery. The two treatment procedures combine to help with being a powerfully effective combination to treat peritoneal mesothelioma. Dr. Schiffman first joined the Allegheny Health Network back in 2014, and this follows a fellowship from the nearby University of Pittsburgh Medical Center.

Get In Touch

Rising Prominence

Dr. Suzanne Schiffman is a surgical oncologist with expertise in treating peritoneal mesothelioma, a rare asbestos-related disease. She works within the Allegheny Health Network (AHN), whose world-class oncology institutes have risen to prominence.

Dr. Schiffman is specialized in minimally invasive surgical procedures. Her ability to perform these procedures benefits her patients, providing them with a shorter recovery time. In addition to treating peritoneal mesothelioma, Dr. Schiffman also treats cancer of the small intestine, pancreas, liver, stomach, and colon.

Message of Hope

Dr. Suzanne Schiffman comforts her patients, telling them that now is not the time to give up. With AHN, they have treatment options and they have hope.

Any Treatment a Patient Might Need

AHN is a highly comprehensive center that can offer almost any treatment a patient might need. Dr. Schiffman works as the lead contact at AHN for patients with peritoneal mesothelioma, an aggressive form of cancer that originates in the lining of the abdomen.

A Message of Hope

Individuals diagnosed with peritoneal mesothelioma often receive a grim message about their disease because of its low survival rate. Around 55 percent of people under 50 live for one year. Unfortunately, the survival rate decreases for people over 75. Only 30 percent of individuals over 75 live for one year. At AHN, this survival rate is improved significantly. Dr. Schiffman comforts her patients, telling them that now is not the time to give up. With AHN, they have treatment options and they have hope.

Article Sources